ORYZON GENOMICS, S.A. «...678910...» Page 7 out of 13 29/12/2022 15:48 ORYZON GENOMICS, S.A. Total number of voting rights and capital Se comunica la inscripción en el Registro Mercantil de Madrid de la escritura de aumento de capital por conversión de obligaciones convertibles. Register number: 19809 20/12/2022 16:33 ORYZON GENOMICS, S.A. Other relevant information La sociedad comunica la conversión de obligaciones convertibles Register number: 19710 12/12/2022 18:16 ORYZON GENOMICS, S.A. Other relevant information ORYZON presents final data from iadademstat’s Phase IIa ALICE trial in acute myeloid leukemia at the American Society of Hematology congress, ASH-2022. Register number: 19580 24/11/2022 18:12 ORYZON GENOMICS, S.A. Other relevant information La sociedad comunica la conversión de obligaciones convertibles Register number: 19317 09/11/2022 07:24 ORYZON GENOMICS, S.A. Other relevant information Approval from the FDA for IND to initiate a collaborative Phase II study with Fox Chase Cancer Center with iadademstat in patients with neuroendocrine carcinomas Register number: 19125 02/11/2022 06:20 ORYZON GENOMICS, S.A. Other relevant information La Sociedad Remite información sobre los estados financieros del tercer trimestre de 2022 Register number: 18966 16/09/2022 07:52 ORYZON GENOMICS, S.A. Other relevant information ORYZON presents preliminary blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder at the European Conference on Mental Health Register number: 18274 01/09/2022 13:40 ORYZON GENOMICS, S.A. Total number of voting rights and capital Ampliación de Capital por conversión de obligaciones Register number: 18100 22/07/2022 07:05 ORYZON GENOMICS, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2022 Register number: 17481 19/07/2022 08:00 ORYZON GENOMICS, S.A. Other relevant information ORYZON announces Cooperative Research and Development Agreement (CRADA) with the U.S. National Cancer Institute (NCI) to develop iadademstat in different cancers Register number: 17424 Page 7 out of 13 «...678910...»